Lincoln Alternative Strategies LLC - 20 Aug 2025 SCHEDULE 13G Report for Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value

Filing Manager: Lincoln Alternative Strategies LLC
Reporting Manager: Lincoln Alternative Strategies LLC
Security: Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value
Shares outstanding: 5.05M shares
Disclosed Ownership: 730K shares
Ownership: 14.5%
Form type: SCHEDULE 13G
Filing time: 27 Aug 2025, 09:15:04 UTC
Date of event: 20 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lincoln Alternative Strategies LLC	14.46%	730K	730K	0	/s/ Stephen Temes	Stephen Temes/Managing Member